The Israeli pharmaceutical company has also announced first quarter results, which beat the analysts’ predictions. | Read More in Front – Globes
Teva acquires Emalex Biosciences for up to $900m
Recent Posts
The Jerusalem Post
WATCH: Anti-draft haredi Jerusalem Faction holds protest at Chords Bridge
April 29, 2026Likud minister contradicts Netanyahu, says US limiting Israel’s actions in Lebanon
April 29, 2026Israel is building homes, but not the homes Israelis need, Shoresh study warns
April 29, 2026Education-based alternatives for antisemitic hate crime offenders – opinion
April 29, 2026
YnetNews
Palestinian woman posed as Israeli Negev resident for more than 20 years
April 29, 2026Watch: IDF drone chases Hezbollah terrorist on motorcycle in southern Lebanon, eliminates him
April 29, 2026UN chief singles out Israel for harsher treatment than Iran, China, Russia, AI study finds
April 29, 2026UK leaders condemn stabbing of two Jews in London amid rising antisemitic incidents
April 29, 2026
Arutz Sheva
Watch: IDF destroys Hezbollah launcher hidden in civilian buildingApril 29, 2026
Extremist haredi rioters block entrance to JerusalemApril 29, 2026
Marc Zell: ‘Iran’s transparent strategy-stall & wait forTrump to face pressure’April 29, 2026
Drone footage: Hezbollah terrorist eliminated while riding a motorcycleApril 29, 2026
JTA
Black Metallica Symphony Tribute show to perform in Tel Aviv
April 29, 2026- Prometheus unbound: Server that can break memory wallApril 29, 2026
- Aidoc raises $150m to prevent diagnostic errorsApril 29, 2026
- April 29, 2026
UAE exit weakens OPEC+ power over oil market but group to stay together, sources say – analysis
April 29, 2026